The American Diabetes Association (ADA)“Standards of Medical Care in Diabetes” includes
the ADA's current clinical practice recommendations and is intended to provide the�…

The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components�…

OBJECTIVE To assess the efficacy and safety of closed-loop insulin delivery compared with
sensor-augmented pump therapy among older adults with type 1 diabetes. RESEARCH�…

The integration of technologies such as continuous glucose monitors, insulin pumps, and
smart pens into diabetes management has the potential to support the transformation of�…

More than one third of US adults age≥ 65 years have diabetes. According to early studies,
61% of all diabetes-related costs in the United States were for individuals age≥ 65 years�…

The American Diabetes Association (ADA)“Standards of Medical Care in Diabetes” includes
the ADA's current clinical practice recommendations and is intended to provide the�…

Abstract The American Diabetes Association (ADA)" Standards of Care in Diabetes"
includes the ADA's current clinical practice recommendations and is intended to provide the�…

OBJECTIVE Continuous glucose monitoring (CGM) is now commonly used in the
management of type 1 diabetes (T1D). The CGM-derived coefficient of variation (CV)�…

Repeated hypoglycemia exposure leads to impaired awareness of hypoglycemia (IAH) and
the development of defective counterregulatory responses. To date, only pancreas or islet�…

Hybrid closed-loop therapy is an emerging technology transforming the management of type
1 diabetes (T1D). Research studies demonstrate glycemic and quality of life benefits of�…